Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0H3HV
|
||||
Former ID |
DIB003912
|
||||
Drug Name |
AP-1030
|
||||
Synonyms |
AP-1102; AP-1130; MS-05; Combined MC1/MC4 receptor agonists, Action Pharma; Melanocortin-1/-4 receptor agonists, ActionPharma; Melanocortin-1/melanocortin-4 receptor agonists, Action Pharma
|
||||
Company |
Action Pharma A/S
|
||||
Structure |
Download2D MOL |
||||
Canonical SMILES |
C1CN([C@@H](C1)C(=O)N[C@H](C(=O)N)C(C)C)C(=O)[C@@H](NC(<br />=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H]<br />(NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC<br />(=O)[C@@H](N)CO)CO)[C@@H](C)CC)[C@@H](C)CC)CO)Cc1c[nH]c<br />n1)Cc1ccccc1)CCCNC(=N)N)Cc1c[nH]c2c1cccc2)CCCCN
|
||||
Target and Pathway | |||||
Target(s) | Melanocyte stimulating hormone receptor | Target Info | Modulator | [1572591] | |
Melanocortin-4 receptor | Target Info | Modulator | [1572591] | ||
Pathway Interaction Database | Syndecan-3-mediated signaling events | ||||
References | |||||
Ref 522018 | ClinicalTrials.gov (NCT00464958) One Year Extension Study To Protocol C2/5/TZ:MS-05. U.S. National Institutes of Health. | ||||
Ref 538812 | (http://www.guidetopharmacology.org/) Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1322). |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.